Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eggschain is a private healthcare technology company focused on blockchain-integrated tracking of biospecimens and medical records, with an initial emphasis on reproductive health and fertility preservation. The company markets a patented chain-of-custody and inventory platform designed to track materials such as sperm, eggs, embryos, cord blood, stem cells, DNA, RNA, tissues, and organs. It has also positioned itself more broadly in longevity and early disease detection, and its website states that it operates under the DBA Longivitate.AI. Eggschain appears to generate revenue through software/platform deployment and related healthcare data services rather than through a traditional therapeutic drug pipeline. The company has highlighted partnerships in fertility care, including Boston IVF, and presents itself as a healthcare/biotech infrastructure and data integrity platform rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eggschain.